Your fact-checks will appear here
American brain-computer interface company
Neuralink — Elon Musk’s neurotechnology company — received U.S. FDA clearance to begin a first‑in‑human clinical study of its brain‑implant device in May 2023, not a full drug approval . Available sou...
A handful of well‑funded startups and established labs are racing to build , and several of those efforts are directly backed by high‑profile philanthropists and investors — from ’s to with and partne...
The regulates implanted brain‑computer interfaces (iBCIs) as medical devices and applies established device pathways and device‑specific guidance to them, including a 2021 final guidance on implanted ...
Neurotech’s competitive landscape is crowded and bifurcated between large medtech incumbents that sell approved implants and broad service networks (e.g., Medtronic, Abbott, Boston Scientific) and a f...
Available reporting and device databases in the provided sources do not list any FDA approvals or clearances specifically for a company named “Neurocept” as of 2025; searches turned up consumer supple...
Available reporting in the provided search results does not list any company named “Neurcept” or detail its products, clearances, or approvals; therefore I cannot confirm which Neurcept products are F...
Available sources in the provided set do not mention a company named “NeurOcept” (or “Neurocept” as a likely variant) raising a Series A or later rounds, nor do they identify which venture capital fir...